Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High frequency of BRCA1 5382insC mutation in Russian breast cancer patients.
Sokolenko AP, Mitiushkina NV, Buslov KG, Bit-Sava EM, Iyevleva AG, Chekmariova EV, Kuligina ESh, Ulibina YM, Rozanov ME, Suspitsin EN, Matsko DE, Chagunava OL, Trofimov DY, Devilee P, Cornelisse C, Togo AV, Semiglazov VF, Imyanitov EN. Sokolenko AP, et al. Among authors: mitiushkina nv. Eur J Cancer. 2006 Jul;42(10):1380-4. doi: 10.1016/j.ejca.2006.01.050. Epub 2006 Jun 5. Eur J Cancer. 2006. PMID: 16737811
CHEK2 1100delC mutation is frequent among Russian breast cancer patients.
Chekmariova EV, Sokolenko AP, Buslov KG, Iyevleva AG, Ulibina YM, Rozanov ME, Mitiushkina NV, Togo AV, Matsko DE, Voskresenskiy DA, Chagunava OL, Devilee P, Cornelisse C, Semiglazov VF, Imyanitov EN. Chekmariova EV, et al. Among authors: mitiushkina nv. Breast Cancer Res Treat. 2006 Nov;100(1):99-102. doi: 10.1007/s10549-006-9227-7. Epub 2006 Jun 7. Breast Cancer Res Treat. 2006. PMID: 16758118
Founder mutations in early-onset, familial and bilateral breast cancer patients from Russia.
Sokolenko AP, Rozanov ME, Mitiushkina NV, Sherina NY, Iyevleva AG, Chekmariova EV, Buslov KG, Shilov ES, Togo AV, Bit-Sava EM, Voskresenskiy DA, Chagunava OL, Devilee P, Cornelisse C, Semiglazov VF, Imyanitov EN. Sokolenko AP, et al. Among authors: mitiushkina nv. Fam Cancer. 2007;6(3):281-6. doi: 10.1007/s10689-007-9120-5. Epub 2007 Feb 28. Fam Cancer. 2007. PMID: 17333477
BRCA1 4153delA founder mutation in Russian ovarian cancer patients.
Krylova NY, Lobeiko OS, Sokolenko AP, Iyevleva AG, Rozanov ME, Mitiushkina NV, Gergova MM, Porhanova TV, Urmancheyeva AF, Maximov SY, Togo AV, Imyanitov EN. Krylova NY, et al. Among authors: mitiushkina nv. Hered Cancer Clin Pract. 2006 Sep 15;4(4):193-6. doi: 10.1186/1897-4287-4-4-193. Hered Cancer Clin Pract. 2006. PMID: 20223023 Free PMC article.
Pattern of clinically relevant mutations in consecutive series of Russian colorectal cancer patients.
Yanus GA, Belyaeva AV, Ivantsov AO, Kuligina ESh, Suspitsin EN, Mitiushkina NV, Aleksakhina SN, Iyevleva AG, Zaitseva OA, Yatsuk OS, Gorodnova TV, Strelkova TN, Efremova SA, Lepenchuk AY, Ochir-Garyaev AN, Paneyah MB, Matsko DE, Togo AV, Imyanitov EN. Yanus GA, et al. Among authors: mitiushkina nv. Med Oncol. 2013;30(3):686. doi: 10.1007/s12032-013-0686-5. Epub 2013 Aug 14. Med Oncol. 2013. PMID: 23943423
High prevalence of GPRC5A germline mutations in BRCA1-mutant breast cancer patients.
Sokolenko AP, Bulanova DR, Iyevleva AG, Aleksakhina SN, Preobrazhenskaya EV, Ivantsov AO, Kuligina ESh, Mitiushkina NV, Suspitsin EN, Yanus GA, Zaitseva OA, Yatsuk OS, Togo AV, Kota P, Dixon JM, Larionov AA, Kuznetsov SG, Imyanitov EN. Sokolenko AP, et al. Among authors: mitiushkina nv. Int J Cancer. 2014 May 15;134(10):2352-8. doi: 10.1002/ijc.28569. Epub 2014 Jan 27. Int J Cancer. 2014. PMID: 24470238 Free article.
Lung carcinomas with EGFR exon 19 insertions are sensitive to gefitinib treatment.
Iyevleva AG, Mitiushkina NV, Karaseva NA, Orlov SV, Volodina LN, Kulikova YE, Lozhkina AM, Ivantsov AO, Tiurin VI, Togo AV, Imyanitov EN. Iyevleva AG, et al. Among authors: mitiushkina nv. J Thorac Oncol. 2014 Apr;9(4):e31-3. doi: 10.1097/JTO.0000000000000106. J Thorac Oncol. 2014. PMID: 24736087 Free article. No abstract available.
Double heterozygotes among breast cancer patients analyzed for BRCA1, CHEK2, ATM, NBN/NBS1, and BLM germ-line mutations.
Sokolenko AP, Bogdanova N, Kluzniak W, Preobrazhenskaya EV, Kuligina ES, Iyevleva AG, Aleksakhina SN, Mitiushkina NV, Gorodnova TV, Bessonov AA, Togo AV, Lubiński J, Cybulski C, Jakubowska A, Dörk T, Imyanitov EN. Sokolenko AP, et al. Among authors: mitiushkina nv. Breast Cancer Res Treat. 2014 Jun;145(2):553-62. doi: 10.1007/s10549-014-2971-1. Epub 2014 May 7. Breast Cancer Res Treat. 2014. PMID: 24800916
46 results